Comparative Cardiovascular Efficacy of SGLT2 Inhibitors, DPP-4 Inhibitors, and GLP-1 Agonists-A Network Meta-analysis

被引：0
|
作者：
Roddick, Alistair J.
Zheng, Sean
机构：
来源：
DIABETES | 2018年 / 67卷
关键词：
D O I：
10.2337/db18-427-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The cardiovascular safety trials of DPP-4 inhibitors, GLP-1 agonists, and SGLT2 inhibitors
    Secrest, Matthew H.
    Udell, Jacob A.
    Filion, Kristian B.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2017, 27 (03) : 194 - 202
  • [2] SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review
    El Mouhayyar, Christopher
    Riachy, Ruba
    Khalil, Abir Bou
    Eid, Asaad
    Azar, Sami
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2020, 2020
  • [3] Association of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors with cardiovascular events stratified by renal function: a network meta-analysis
    Roddick, A.
    Zheng, S. L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2471 - 2471
  • [4] Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review
    Aroda, Vanita R.
    Henry, Robert R.
    Han, Jenny
    Huang, Wenying
    DeYoung, Mary Beth
    Darsow, Tamara
    Hoogwerf, Byron J.
    CLINICAL THERAPEUTICS, 2012, 34 (06) : 1247 - 1258
  • [5] The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system
    Schernthaner, Guntram
    Mogensen, Carl Erik
    Schernthaner, Gerit-Holger
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (05): : 306 - 323
  • [6] SGLT2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors and Risk of All-Cause Hospitalization
    Lyu, Beini
    Grams, Morgan
    Chang, Alex R.
    Inker, Lesley A.
    Coresh, Josef
    Shin, Jung-Im
    DIABETES, 2021, 70
  • [7] The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
    Giugliano, Dario
    Longo, Miriam
    Signoriello, Simona
    Maiorino, Maria Ida
    Solerte, Bruno
    Chiodini, Paolo
    Esposito, Katherine
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [8] The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs
    Dario Giugliano
    Miriam Longo
    Simona Signoriello
    Maria Ida Maiorino
    Bruno Solerte
    Paolo Chiodini
    Katherine Esposito
    Cardiovascular Diabetology, 21
  • [9] Association of SGLT2 Inhibitors and DPP-4 Inhibitors vs. GLP-1 Agonists with Incident CKD in US Veterans
    Kalantar-Zadeh, Kamyar
    Rhee, Connie
    Narasaki, Yoko
    You, Amy S.
    Dashputre, Ankur A.
    Sumida, Keiichi
    Thomas, Fridtjof
    Streja, Elani
    Potukuchi, Praveen Kumar
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 697 - 698
  • [10] Comparative Effectiveness of SGLT-2 Inhibitors, DPP-4 Inhibitors, and GLP-1 Agonists in US Veterans with and Without CKD
    Narasaki, Yoko
    Kovesdy, Csaba P.
    You, Amy S.
    Potukuchi, Praveen Kumar
    Dashputre, Ankur A.
    Sumida, Keiichi
    Thomas, Fridtjof
    Streja, Elani
    Kalantar-Zadeh, Kamyar
    Rhee, Connie
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 264 - 264
12345